Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8
- 28 February 1997
- journal article
- Published by Elsevier in Human Immunology
- Vol. 52 (2), 109-118
- https://doi.org/10.1016/s0198-8859(96)00292-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic miceEuropean Journal of Immunology, 1996
- Cytokines and clinical gene therapyEuropean Journal of Immunology, 1995
- Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogeneCellular Immunology, 1993
- Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesCell, 1993
- Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA‐A2 in its recognition by cytotoxic T lymphocytesEuropean Journal of Immunology, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Strong xenogeneic HLA response in transgenic mice after introducing an α3 domain into HLA B27Nature, 1990
- The α3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulationEuropean Journal of Immunology, 1989
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987